Vivos Therapeutics’ stock soars as sleep apnea device gets regulatory clearance
November 29, 2023 at 11:09 AM EST
Vivos Therapeutics jumped more than 270% after the FDA cleared the company's devices for severe sleep apnea.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.